终末期肝病与营养相关研究的可视化分析

摘要/Abstract

摘要： 目的通过文献计量分析总结终末期肝病营养相关研究的发展概况及趋势,提供新的见解。方法收集Web of Science核心数据集从1992—2021年1月30日的肝病营养方面的英文文献,通过VOSviewer软件对相关文献进行可视化分析,探索其相关研究的作者、期刊分布及关键词分布。结果《CLINICAL NUTRITION》杂志发文量最多,成果最突出的研究者是Jenab M和 Bamia C。研究热点为:非酒精性脂肪性肝病、肝硬化、肝癌、营养不良、生活方式干预等。结论通过对期刊、引文、作者及关键词等相关数据的可视化分析,构建了一幅关于ESLD营养研究的全景图画,旨在为临床工作及研究提供建议和思路。

关键词: 终末期肝病, 非酒精性脂肪性肝病, 营养评价, 营养支持, VOSviewer, 可视化分析

Abstract: Objective To summarize the research progress and trends on the association of nutrition with end-stage liver disease (ESLD) via bibliometric analysis. Methods English literature on liver disease-associated nutrition problems from the core data set of Web of Science from January 30 of 1992 to,2021 were collected. The related literature were visually analyzed through the VOSviewer software, and the distributions of related authors, journals and key words were explored. Results "CLINICAL NUTRITION" magazine has the largest number of publications. The most outstanding researchers are Jenab M and Bamia C. The research hotspots are: non-alcoholic fatty liver disease, liver cirrhosis, liver cancer, malnutrition, lifestyle intervention, etc.Conclusion By visualized analysis on the related data including journals, citations and keywords, a panoramic picture of nutrition research on ESLD was constructed which may provide insight into the clinical work and research.

Key words: End-stage liver disease, Non-alcoholic fatty liver disease, Nutritional assessment, Nutritional management, VOSviewer, Visualized analysis

杨诚, 杨华升, 胡建华, 张丽丽, 徐琛. 终末期肝病与营养相关研究的可视化分析[J]. 肝脏, 2023, 28(1): 65-69.

YANG Cheng, YANG Hua-sheng, HU Jian-hua, ZHANG Li-li, XU Chen. Visualized analysis on the association of nutrition with end-stage liver disease[J]. Chinese Hepatolgy, 2023, 28(1): 65-69.

参考文献

[1] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease.J Hepatol,2019,70(1):172-193.
[2] Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections.Clin Gastroenterol Hepatol,2010,8(11):979-985.
[3] Merli M, Giusto M, Lucidi C, et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.Metab Brain Dis, 2013,28(2):281-284.
[4] Huisman EJ, Trip EJ, Siersema PD, et al. Protein energy malnutrition predicts complications in liver cirrhosis.Eur J Gastroenterol Hepatol,2011,23(11):982-989.
[5] Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis.Clin Gastroenterol Hepatol,2012,10(2):166-73, 173.e1.
[6] Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation.J Am Coll Surg,2010,211(2):271-278.
[7] Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies.Clin Gastroenterol Hepatol,2012,10(2):117-125.
[8] Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score.J Cachexia Sarcopenia Muscle,2017,8(1):113-121.
[9] Young S, Kwarta E, Azzam R, et al. Nutrition assessment and support in children with end-stage liver disease.Nutr Clin Pract,2013,28(3):317-329.
[10] Peyret B, Collardeau S, Touzet S, et al. Prevalence of liver complications in children receiving long-term parenteral nutrition.Eur J Clin Nutr,2011,65(6):743-749.
[11] Mazurak VC, Tandon P, Montano-Loza AJ. Nutrition and the transplant candidate.Liver Transpl,2017,23(11):1451-1464.
[12] Kaido T, Ogawa K, Fujimoto Y, et al. OP002 IMPACT OF SARCOPENIA AND PERIOPERATIVE NUTRITIONAL THERAPY ON SURVIVAL IN PATIENTS UNDERGOING LIVING DONOR LIVER TRANSPLANTATION.Clinical Nutrition,2013,32:S1-S1.
[13] Ando Y, Ishigami M, Ito T, et al. Sarcopenia impairs health-related quality of life in cirrhotic patients.Eur J Gastroenterol Hepatol,2019,31(12):1550-1556.
[14] Montano-Loza AJ, Meza-Junco J, Baracos VE, et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.Liver Transpl,2014,20(6):640-648.
[15] Peng S, Plank LD, McCall JL, et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study.Am J Clin Nutr,2007,85(5):1257-1266.
[16] Dalle S, Rossmeislova L, Koppo K. The Role of Inflammation in Age-Related Sarcopenia.Front Physiol,2017,8:1045.
[17] Goldberg D, Ditah IC, Saeian K, et al. Changes in the Prevalence of Hepatitis C Virus Infection,Nonalcoholic Steatohepatitis,and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.Gastroenterology,2017,152(5):1090-1099.e1.
[18] Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults:The next frontier in the epidemic.Hepatology,2017,65(6):2100-2109.
[19] Hart CL, Morrison DS, Batty GD, et al. Effect of body mass index and alcohol consumption on liver disease:analysis of data from two prospective cohort studies.BMJ,2010,340:c1240.
[20] Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.Lancet,1997,349(9055):825-832.
[21] Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology,2004,127:S87-S96.
[22] Rothwell JA, Murphy N, Bešević J, et al. Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort.Clin Gastroenterol Hepatol,2020,S1542-3565(20)31635-31639.
[23] Duarte-Salles T, Fedirko V, Trichopoulou A, et al. Dairy products and risk of hepatocellular carcinoma: The European Prospective Investigation into Cancer and Nutrition (EPIC).Journal of Hepatology,2013,58:S260.
[24] Stepien M, Duarte-Salles T, Fedirko V, et al. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.Eur J Nutr,2016,55(1):7-20.
[25] Bamia C, Lagiou P, Jenab M, et al. Coffee,tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population:multicentre,prospective cohort study.Int J Cancer,2015,136(8):1899-1908.
[26] Fedirko V, Duarte-Salles T, Bamia C, et al. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations:a nested case-control study.Hepatology,2014,60(4):1222-1230.
[27] Hughes DJ, Duarte-Salles T, Hybsier S, et al. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.Am J Clin Nutr,2016,104(2):406-414.
[28] Stepien M, Hughes DJ, Hybsier S, et al. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.Br J Cancer,2017,116(5):688-696.
[29] Assi N, Fages A, Vineis P, et al. A statistical framework to model the meeting-in-the-middle principle using metabolomic data:application to hepatocellular carcinoma in the EPIC study.Mutagenesis,2015,30(6):743-753.